A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

Clinical trial NCT05572684 · TERMINATED

Trial details

NCT number: NCT05572684
Sponsor: NextCure, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumors Microsatellite Instability Low Microsatellite Instability High Microsatellite Stable Ovarian Cancer Gastric Cancer Colo-rectal Cancer Esophageal Cancer Endometrial Cancer Head Neck Cancer Cervical Cancer Lung Cancer

Start date: 2022-10-06
Primary completion: 2025-04-30
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.